Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Adawi Kamal, Chief Financial Officer. Insider active across 2 companies, notably EXAGEN INC.. In total, 10 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €51k. Activity tracked since 4 February 2022. The latest transaction was filed on 15 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Adawi Kamal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Adawi Kamal is the Chief Financial Officer and Corporate Secretary of EXAGEN INC. In his role, he is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. With a strong background in finance, he contributes to EXAGEN INC.'s overall strategy by ensuring that financial resources are utilized effectively and efficiently.